Contrast

Contact

Share

MyChart

Help

Ena Williams appointed senior vice president and chief nursing officer at Yale New Haven Hospital

Thursday, April 5, 2018

New Haven, CT (April 5, 2018) – Ena Williams, MBA, RN, CNEP has been appointed senior vice president and chief nursing officer (CNO) for Yale New Haven Hospital (YNHH). Williams has been serving as interim CNO since the retirement of the previous CNO in April 2017. Williams has indirect oversight for all nursing practice at YNHH and direct oversight for surgical, musculoskeletal, neuroscience, and nursing resource operations center, with a special focus on safety and quality, the patient experience, human resources and integration and alignment of the nursing strategic plan.

Williams joined YNHH in 1992 as a staff nurse in perioperative services and has held a number of different leadership positions during her 26 year tenure, including nursing director of Perioperative Services and vice president and associate CNO, among others. She obtained her BS in Health Studies and Management from Charter Oak State College, BSN from Western Governors University, MS in Science Management from Albertus Magnus College, MBA from Albertus Magnus and is currently completing her PhD in Leadership and Organizational Change from Walden University. Ena is also board certified in executive nursing practice.

“We are delighted to have Ena officially named chief nursing officer,” said Richard D’Aquila, president Yale New Haven Hospital. “A regionally and nationally recognized nursing leader, Ena is known for her commitment to nursing empowerment and leadership development.”

Prior to joining YNHH, Williams worked as a staff nurse leader at Bronx Lebanon Hospital. She served as an OR supervisor for four years at Hargreaves Memorial Hospital and another four years as a charge nurse at University Hospital of the West Indies both in Jamaica.

Williams is very active in the community, having served on the advisory board of the Women to Women initiative led by the Department of Public Health, expanding Yale New Haven Hospital’s collaboration with the New Haven Police Academy League summer camp and leading a number of community health initiatives with the Southern Chapter of the National Black Nurses Association, where she also served as president. Last year she was named as a recipient of The National Black Nurses Association Trailblazer Award Winner.

Williams and her husband Leonard live in Hamden and have three children.

Yale New Haven Hospital (YNHH), part of Yale New Haven Health, is a nationally recognized, 1,541-bed, not-for-profit hospital serving as the primary teaching hospital for the Yale School of Medicine (YSM). Founded as the fourth voluntary hospital in the U.S. in 1826, today, YNHH has two New Haven-based campuses, and also includes Yale New Haven Children's Hospital, Yale New Haven Psychiatric Hospital and Smilow Cancer Hospital. YNHH has received Magnet designation from the American Nurses Credentialing Center, the nation’s highest honor of nursing excellence. YNHH has a combined medical staff of about 4,500 university and community physicians practicing in more than 100 specialties. www.ynhh.org

Similar Articles

9/15/2021

Marna Borgstrom to retire in 2022 as CEO of Yale New Haven Health

New Haven, CT (Sept. 15, 2021) – After more than 43 years of exceptional service, Marna P. Borgstom has announced her intent to retire as chief executive officer of Yale New Haven Health. Her retirement is effective on March 25 2022.

9/15/2021

Christopher O’Connor to become CEO of Yale New Haven Health

New Haven, CT (Sept. 15, 2021) – Christopher O’Connor has been named the CEO of Yale New Haven Health (YNHHS), effective March 25, 2022 when current CEO Marna P. Borgstrom retires, announced Vince Calarco, Chair of the YNHHS Board of Trustees. O’Connor currently serves as president of the Health System having been named to that position in August of 2020.

9/1/2021

Outpatient Monoclonal Antibody Treatment decreases hospitalization risk in COVID-19 patients

New Haven, CT (September 1, 2021) – While not a new treatment, monoclonal antibody therapy is being administered more regularly and effectively to patients with mild to moderate COVID-19 with excellent results.